OPTIMUS TECHNOLOGIES AND MITSUI & CO. EXECUTE STRATEGIC MOU FOR GLOBAL DISTRIBUTION OF BIODIESEL SOLUTIONS

OPTIMUS TECHNOLOGIES AND MITSUI & CO. EXECUTE STRATEGIC MOU FOR GLOBAL DISTRIBUTION OF BIODIESEL SOLUTIONS

PITTSBURGH, Dec. 9, 2025 /PRNewswire/ -- Optimus Technologies, a leader in advanced biodiesel engine technology, today announced the signing of a Memorandum of Understanding (MOU) with Mitsui & Co., Ltd. ("Mitsui"), one of the world's most...

swop 2025 Concludes Decade Anniversary with Record-Breaking Success, Heralding the Future of interpack China

swop 2025 Concludes Decade Anniversary with Record-Breaking Success, Heralding the Future of interpack China

SHANGHAI, Dec. 8, 2025 /PRNewswire/ -- The Shanghai World of Packaging (swop), co-organized by Messe Düsseldorf (Shanghai) Co., Ltd. and Adsale Exhibition Services Ltd., successfully concluded its landmark tenth-anniversary edition in Shanghai on...

CIMC Unveils New Global Brand Logo and Visual Identity System

CIMC Unveils New Global Brand Logo and Visual Identity System

SHENZHEN, China, Dec. 8, 2025 /PRNewswire/ -- On December 5, 2025, China International Marine Containers (Group) Co., Ltd. (CIMC) unveiled its new brand logo and visual identity system to a global audience. Marking the company's most significant...

HiroPharmaConsulting (R) Granted Patent for AI-enabled Reliability Assurance Method for Pharmacovigilance Systems

HiroPharmaConsulting (R) Granted Patent for AI-enabled Reliability Assurance Method for Pharmacovigilance Systems

OSAKA, Japan, Dec. 4, 2025 /PRNewswire/ -- HiroPharmaConsulting (R) Co., Ltd. announced that it has received a patent for an innovative Good Pharmacovigilance Practice (GVP) Computerized System Validation (CSV) methodology designed to ensure the...

NX Group Participates in Shanghai's 8th China International Import Expo (CIIE)

NX Group Participates in Shanghai's 8th China International Import Expo (CIIE)

TOKYO, Dec. 3, 2025 /PRNewswire/ -- NIPPON EXPRESS HOLDINGS, INC. took part in the six-day 8th China International Import Expo (CIIE) held in Shanghai, China from Wednesday, November 5 to Monday, November 10. Logo:...

Asurion to Acquire Domestic & General, Establishing a Global Leader in Technology and Appliance Care Committed to Excellence in Customer Service

Asurion to Acquire Domestic & General, Establishing a Global Leader in Technology and Appliance Care Committed to Excellence in Customer Service

The combined company will accelerate Asurion's vision to become CTO of the home, by delivering seamless, intelligent care for every connected device and appliance in the home and making technology simpler, more reliable, and more sustainable for...

Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy

Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy

SHANGHAI and HONG KONG, Dec. 2, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...

Zeekr Group Announces November 2025 Delivery Update

Zeekr Group Announces November 2025 Delivery Update

HANGZHOU, China, Dec. 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its delivery results for November 2025. In...

NX China Receives China's Highest Rating of Class 5A Logistics Enterprise

NX China Receives China's Highest Rating of Class 5A Logistics Enterprise

- Becoming 1st Japanese-affiliated Logistics Company to Receive This Top Rating - TOKYO, Dec. 1, 2025 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereinafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., was recognized by the...

The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma

The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma

CHENGDU, China, Nov. 28, 2025 /PRNewswire/ -- Recently, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990)'s TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy for advanced or metastatic...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • menu
    menu